APA (7th ed.) Citation

B, A., KS, A., & JR, B. (2022). Reply to Aljabali et al. Comment on "Abbas et al. The Safety and Efficacy of Nusinersen in the Treatment of Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Medicina 2022, 58, 213". Medicina (Kaunas, Lithuania), 58(6), . https://doi.org/10.3390/medicina58060793

Chicago Style (17th ed.) Citation

B, Abdelazeem, Abbas KS, and Brašić JR. "Reply to Aljabali Et Al. Comment on "Abbas Et Al. The Safety and Efficacy of Nusinersen in the Treatment of Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Medicina 2022, 58, 213"." Medicina (Kaunas, Lithuania) 58, no. 6 (2022). https://doi.org/10.3390/medicina58060793.

MLA (9th ed.) Citation

B, Abdelazeem, et al. "Reply to Aljabali Et Al. Comment on "Abbas Et Al. The Safety and Efficacy of Nusinersen in the Treatment of Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Medicina 2022, 58, 213"." Medicina (Kaunas, Lithuania), vol. 58, no. 6, 2022, https://doi.org/10.3390/medicina58060793.